SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001193125-19-249241
Filing Date
2019-09-19
Accepted
2019-09-19 12:40:04
Documents
4
Group Members
LEDO CAPITAL, LLCNEWTYN CAPITAL PARTNERS, LPNEWTYN PARTNERS, LPNOAH G. LEVY

Document Format Files

Seq Description Document Type Size
1 SC 13D d767559dsc13d.htm SC 13D 113703
2 EX-99.1 d767559dex991.htm EX-99.1 96263
3 EX-99.2 d767559dex992.htm EX-99.2 84358
4 EX-99.3 d767559dex993.htm EX-99.3 7401
  Complete submission text file 0001193125-19-249241.txt   303376
Mailing Address ONE BROADWAY 14TH FLOOR CAMBRIDGE MA 02142
Business Address ONE BROADWAY 14TH FLOOR CAMBRIDGE MA 02142 617-441-1000
MERRIMACK PHARMACEUTICALS INC (Subject) CIK: 0001274792 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-86778 | Film No.: 191101349
SIC: 2834 Pharmaceutical Preparations

Mailing Address 60 EAST 42ND STREET SUITE 960 NEW YORK NY 10165
Business Address 60 EAST 42ND STREET SUITE 960 NEW YORK NY 10165 212-446-2465
Newtyn Management, LLC (Filed by) CIK: 0001569241 (see all company filings)

IRS No.: 453017573 | State of Incorp.: NY | Fiscal Year End: 1231
Type: SC 13D